Romark Laboratories Selects DSG for Influenza Study

DSG’s suite of eClinical solutions chosen for Phase III study of new treatments for acute uncomplicated influenza March 11, 2014 As influenza continues to lead to more than 226,000 hospitalizations and 24,000 deaths annually in the United States alone, new treatments are critical for fighting the latest strains of the virus. To combat this seasonal issue, Romark Laboratories will complete …